Pura Vida Investments is a venture capital firm that invests in healthcare sector.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Pura Vida Investments is a venture capital firm that invests in healthcare sector.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
4/2021 | Ultivue | Series D | 50M |
4/2021 | Vizgen | Series B | 0 |
4/2021 | LUMICKS | Series D | 0 |
3/2021 | ATAI Life Sciences | Series D | 0 |
12/2021 | NanoMosaic | Series A | 0 |
7/2021 | Exo | Series C | 0 |
5/2021 | Caris Life Sciences | Private Equity Round | 0 |
1/2021 | Sensei Biotherapeutics | Series B | 0 |
6/2019 | Acutus Medical | Series D | 0 |
7/2018 | MedAvail | Series D | 0 |
12/2021 | Freenome | Series D | 300M |
1/2016 | V-Wave | Series B | 0 |
12/2016 | Motus GI | Venture Round | 0 |
1/2021 | DarioHealth | Post-IPO Equity | 70M |
10/2014 | MedAvail | Series C | 0 |
9/2022 | Solid Biosciences | Post-IPO Equity | 75M |
4/2022 | Lyra Therapeutics | Post-IPO Equity | 0 |
2/2022 | Nalu Medical | Venture Round | 0 |
11/2021 | SLANG Worldwide | Post-IPO Debt | 0 |
4/2018 | V-Wave | Series C | 0 |
4/2021 | Willow | Series C | 26.8M |
9/2020 | V-Wave | Series C | 0 |
9/2022 | Sonendo | Post-IPO Equity | 63M |
11/2020 | MedAvail | Series E | 0 |
1/2022 | Metagenomi | Series B | 0 |
3/2021 | Field Trip Health | Post-IPO Equity | 0 |
5/2021 | NeoGenomics | Post-IPO Equity | 0 |
2/2022 | Beta Bionics | Series C | 0 |
1/2023 | Monogram Health | Series C | 0 |
10/2021 | Science 37 | Post-IPO Equity | 0 |
11/2020 | ATAI Life Sciences | Series C | 0 |
4/2022 | Lyra Therapeutics | Post-IPO Equity | 0 |
2/2022 | Nalu Medical | Venture Round | 0 |
2/2022 | Beta Bionics | Series C | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
1/2022 | Metagenomi | Series B | 0 |
12/2021 | Freenome | Series D | 0 |
12/2021 | NanoMosaic | Series A | 0 |
11/2021 | SLANG Worldwide | Post-IPO Debt | 0 |
10/2021 | Science 37 | Post-IPO Equity | 0 |
7/2021 | Exo | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|